Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
MRNA
REGN
Add up to 3 more stocks
MRNA
Moderna, Inc.
+4.17%
$197.94+7.93Delayed quote: Oct 5, 2026, 12:40 PM EDT
Market Cap
$78.54B
52W Range
$22.28 - $208.90
REGN
Regeneron Pharmaceuticals, Inc.
-1.70%
$722.69-12.51Delayed quote: Oct 5, 2026, 12:40 PM EDT
Market Cap
$74.45B
52W Range
$541.00 - $859.34
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 17.88 |
| Forward P/E | N/A | 13.02 |
| PEG Ratio | N/A | 2.82 |
| P/B Ratio | 11.62 | 2.35 |
| P/S Ratio | 35.25 | 4.79 |
| P/FCF Ratio | N/A | 21.14 |
| EV/EBITDA | N/A | 16.45 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 55.4% | 84.9% |
| Operating Margin | -158.1% | 25.6% |
| Net Margin | -141.4% | 27.9% |
| ROE | -46.6% | 13.7% |
| ROA | -28.8% | 10.4% |
| ROIC | -39.2% | 9.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.29 | 3.34 |
| Quick Ratio | 2.18 | 2.78 |
| Debt/Equity | 0.19 | 0.06 |
| Interest Coverage | -307.40 | 81.69 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | 0.5% |
| Payout Ratio | N/A | 9.2% |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.